Literature DB >> 19928916

Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model.

Debananda Das1, Yasuhiro Koh, Yasushi Tojo, Arun K Ghosh, Hiroaki Mitsuya.   

Abstract

Reliable and robust prediction of the binding affinity for drug molecules continues to be a daunting challenge. We simulated the binding interactions and free energy of binding of nine protease inhibitors (PIs) with wild-type and various mutant proteases by performing GBSA simulations in which each PI's partial charge was determined by quantum mechanics (QM) and the partial charge accounts for the polarization induced by the protease environment. We employed a hybrid solvation model that retains selected explicit water molecules in the protein with surface-generalized Born (SGB) implicit solvent. We examined the correlation of the free energy with the antiviral potency of PIs with regard to amino acid substitutions in protease. The GBSA free energy thus simulated showed strong correlations (r > 0.75) with antiviral IC(50) values of PIs when amino acid substitutions were present in the protease active site. We also simulated the binding free energy of PIs with P2-bis-tetrahydrofuranylurethane (bis-THF) or related cores, utilizing a bis-THF-containing protease crystal structure as a template. The free energy showed a strong correlation (r = 0.93) with experimentally determined anti-HIV-1 potency. The present data suggest that the presence of selected explicit water in protein and protein polarization-induced quantum charges for the inhibitor, compared to lack of explicit water and a static force-field-based charge model, can serve as an improved lead optimization tool and warrants further exploration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19928916      PMCID: PMC2860540          DOI: 10.1021/ci900320p

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  50 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease.

Authors:  José C Clemente; Rebecca E Moose; Reena Hemrajani; Lisa R S Whitford; Lakshmanan Govindasamy; Robbie Reutzel; Robert McKenna; Mavis Agbandje-McKenna; Maureen M Goodenow; Ben M Dunn
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

3.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

Review 4.  Screening in a spirit haunted world.

Authors:  Brian K Shoichet
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

5.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

6.  Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.

Authors:  Arun K Ghosh; Perali Ramu Sridhar; Sofiya Leshchenko; Azhar K Hussain; Jianfeng Li; Andrey Yu Kovalevsky; D Eric Walters; Joseph E Wedekind; Valerie Grum-Tokars; Debananda Das; Yasuhiro Koh; Kenji Maeda; Hiroyuki Gatanaga; Irene T Weber; Hiroaki Mitsuya
Journal:  J Med Chem       Date:  2006-08-24       Impact factor: 7.446

7.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

8.  Stereoselective photochemical 1,3-dioxolane addition to 5-alkoxymethyl-2(5H)-furanone: synthesis of bis-tetrahydrofuranyl ligand for HIV protease inhibitor UIC-94017 (TMC-114).

Authors:  Arun K Ghosh; Sofiya Leshchenko; Marcus Noetzel
Journal:  J Org Chem       Date:  2004-11-12       Impact factor: 4.354

9.  GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.

Authors:  Yasuhiro Koh; Debananda Das; Sofiya Leschenko; Hirotomo Nakata; Hiromi Ogata-Aoki; Masayuki Amano; Maki Nakayama; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

10.  Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.

Authors:  Milan Kozísek; Jenelle Bray; Pavlína Rezácová; Klára Sasková; Jirí Brynda; Jana Pokorná; Fabrizio Mammano; Lubomír Rulísek; Jan Konvalinka
Journal:  J Mol Biol       Date:  2007-10-03       Impact factor: 5.469

View more
  11 in total

1.  Effect of explicit water molecules on ligand-binding affinities calculated with the MM/GBSA approach.

Authors:  Paulius Mikulskis; Samuel Genheden; Ulf Ryde
Journal:  J Mol Model       Date:  2014-05-29       Impact factor: 1.810

2.  Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach.

Authors:  Gurpreet K Grewal; Khuraijam D Singh; Neha Kanojia; Chitra Rawat; Samiksha Kukal; Ajay Jajodia; Anshika Singhal; Richa Misra; Selvaraman Nagamani; Karthikeyan Muthusamy; Ritushree Kukreti
Journal:  Pharm Res       Date:  2017-04-21       Impact factor: 4.200

3.  Binding affinity prediction with property-encoded shape distribution signatures.

Authors:  Sourav Das; Michael P Krein; Curt M Breneman
Journal:  J Chem Inf Model       Date:  2010-02-22       Impact factor: 4.956

4.  Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study.

Authors:  Chandrabose Selvaraj; Jeyachandran Sivakamavalli; Baskaralingam Vaseeharan; Poonam Singh; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2014-07-20       Impact factor: 1.810

5.  Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.

Authors:  Sathya Babu; Santhosh Kumar Nagarajan; Sruthy Sathish; Vir Singh Negi; Honglae Sohn; Thirumurthy Madhavan
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

6.  In Silico Screening, Alanine Mutation, and DFT Approaches for Identification of NS2B/NS3 Protease Inhibitors.

Authors:  R Balajee; V Srinivasadesikan; M Sakthivadivel; P Gunasekaran
Journal:  Biochem Res Int       Date:  2016-02-25

7.  Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl2 as detoxifiers.

Authors:  N Engstrom; P Saenz-Méndez; J Scheers; N Scheers
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

8.  Exploring the Resistance Mechanisms of Distal D835V Mutation in FLT3 to Inhibitors.

Authors:  Zhiwei Wang; Baichun Hu; Yu An; Jian Wang
Journal:  Oxid Med Cell Longev       Date:  2022-03-28       Impact factor: 6.543

9.  A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.

Authors:  Selvaraman Nagamani; Karthikeyan Muthusamy
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

10.  Evaluating Iso-Mukaadial Acetate and Ursolic Acid Acetate as Plasmodium falciparum Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase Inhibitors.

Authors:  Francis Opoku; Penny P Govender; Ofentse J Pooe; Mthokozisi B C Simelane
Journal:  Biomolecules       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.